These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 14662774

  • 1. Expression of NAG-1, a transforming growth factor-beta superfamily member, by troglitazone requires the early growth response gene EGR-1.
    Baek SJ, Kim JS, Nixon JB, DiAugustine RP, Eling TE.
    J Biol Chem; 2004 Feb 20; 279(8):6883-92. PubMed ID: 14662774
    [Abstract] [Full Text] [Related]

  • 2. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
    Baek SJ, Wilson LC, Hsi LC, Eling TE.
    J Biol Chem; 2003 Feb 21; 278(8):5845-53. PubMed ID: 12475986
    [Abstract] [Full Text] [Related]

  • 3. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1.
    Cheng S, Afif H, Martel-Pelletier J, Pelletier JP, Li X, Farrajota K, Lavigne M, Fahmi H.
    J Biol Chem; 2004 May 21; 279(21):22057-65. PubMed ID: 15023995
    [Abstract] [Full Text] [Related]

  • 4. Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells.
    Shimada T, Kojima K, Yoshiura K, Hiraishi H, Terano A.
    Gut; 2002 May 21; 50(5):658-64. PubMed ID: 11950812
    [Abstract] [Full Text] [Related]

  • 5. 15-Deoxy-delta12,14-PGJ2, but not troglitazone, modulates IL-1beta effects in human chondrocytes by inhibiting NF-kappaB and AP-1 activation pathways.
    Boyault S, Simonin MA, Bianchi A, Compe E, Liagre B, Mainard D, Bécuwe P, Dauça M, Netter P, Terlain B, Bordji K.
    FEBS Lett; 2001 Jul 13; 501(1):24-30. PubMed ID: 11457450
    [Abstract] [Full Text] [Related]

  • 6. Magnitude of peroxisome proliferator-activated receptor-gamma activation is associated with important and seemingly opposite biological responses in breast cancer cells.
    Clay CE, Namen AM, Atsumi G, Trimboli AJ, Fonteh AN, High KP, Chilton FH.
    J Investig Med; 2001 Sep 13; 49(5):413-20. PubMed ID: 11523697
    [Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor gamma1 (PPARgamma1) expresses in rat mesangial cells and PPARgamma agonists modulate its differentiation.
    Asano T, Wakisaka M, Yoshinari M, Iino K, Sonoki K, Iwase M, Fujishima M.
    Biochim Biophys Acta; 2000 Jun 02; 1497(1):148-54. PubMed ID: 10838168
    [Abstract] [Full Text] [Related]

  • 8. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
    Sinha D, Addya S, Murer E, Boden G.
    Metabolism; 1999 Jun 02; 48(6):786-91. PubMed ID: 10381155
    [Abstract] [Full Text] [Related]

  • 9. DR1-like element in human topoisomerase IIalpha gene involved in enhancement of etoposide-induced apoptosis by PPARgamma ligand.
    Kanbe E, Abe A, Towatari M, Kawabe T, Saito H, Emi N.
    Exp Hematol; 2003 Apr 02; 31(4):300-8. PubMed ID: 12691917
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cyclooxygenase inhibitors induce the expression of the tumor suppressor gene EGR-1, which results in the up-regulation of NAG-1, an antitumorigenic protein.
    Baek SJ, Kim JS, Moore SM, Lee SH, Martinez J, Eling TE.
    Mol Pharmacol; 2005 Feb 02; 67(2):356-64. PubMed ID: 15509713
    [Abstract] [Full Text] [Related]

  • 12. Troglitazone antagonizes tumor necrosis factor-alpha-induced reprogramming of adipocyte gene expression by inhibiting the transcriptional regulatory functions of NF-kappaB.
    Ruan H, Pownall HJ, Lodish HF.
    J Biol Chem; 2003 Jul 25; 278(30):28181-92. PubMed ID: 12732648
    [Abstract] [Full Text] [Related]

  • 13. Effect of PPARgamma ligands on the viability of gastric epithelial cells.
    Kojima K, Shimada T, Mitobe Y, Yoshiura K, Hiraishi H, Terano A.
    Aliment Pharmacol Ther; 2002 Apr 25; 16 Suppl 2():67-73. PubMed ID: 11966526
    [Abstract] [Full Text] [Related]

  • 14. 15-Deoxy-delta 12,14-prostaglandin J2 and thiazolidinediones activate the MEK/ERK pathway through phosphatidylinositol 3-kinase in vascular smooth muscle cells.
    Takeda K, Ichiki T, Tokunou T, Iino N, Takeshita A.
    J Biol Chem; 2001 Dec 28; 276(52):48950-5. PubMed ID: 11687581
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective effects of PPARgamma agonists against oxidative insults in HT-22 cells.
    Aoun P, Watson DG, Simpkins JW.
    Eur J Pharmacol; 2003 Jul 04; 472(1-2):65-71. PubMed ID: 12860474
    [Abstract] [Full Text] [Related]

  • 16. Induction of differentiation and peroxisome proliferator-activated receptor gamma expression in colon cancer cell lines by troglitazone.
    Kato M, Kusumi T, Tsuchida S, Tanaka M, Sasaki M, Kudo H.
    J Cancer Res Clin Oncol; 2004 Feb 04; 130(2):73-9. PubMed ID: 14634802
    [Abstract] [Full Text] [Related]

  • 17. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-delta and peroxisome proliferator-activated receptor-gamma.
    Takata Y, Kitami Y, Yang ZH, Nakamura M, Okura T, Hiwada K.
    Circ Res; 2002 Sep 06; 91(5):427-33. PubMed ID: 12215492
    [Abstract] [Full Text] [Related]

  • 18. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
    Takenokuchi M, Saigo K, Nakamachi Y, Kawano S, Hashimoto M, Fujioka T, Koizumi T, Tatsumi E, Kumagai S.
    Acta Haematol; 2006 Sep 06; 116(1):30-40. PubMed ID: 16809887
    [Abstract] [Full Text] [Related]

  • 19. EGR1 expression: a calcium and ERK1/2 mediated PPARγ-independent event involved in the antiproliferative effect of 15-deoxy-Δ12,14-prostaglandin J2 and thiazolidinediones in breast cancer cells.
    Chbicheb S, Yao X, Rodeau JL, Salamone S, Boisbrun M, Thiel G, Spohn D, Grillier-Vuissoz I, Chapleur Y, Flament S, Mazerbourg S.
    Biochem Pharmacol; 2011 May 01; 81(9):1087-97. PubMed ID: 21338579
    [Abstract] [Full Text] [Related]

  • 20. A new class of peroxisome proliferator-activated receptor gamma (PPARgamma) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes.
    Qin C, Morrow D, Stewart J, Spencer K, Porter W, Smith R, Phillips T, Abdelrahim M, Samudio I, Safe S.
    Mol Cancer Ther; 2004 Mar 01; 3(3):247-60. PubMed ID: 15026545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.